{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T11:35:49Z","timestamp":1789385749957,"version":"build-2803163510"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,4]],"date-time":"2026-01-04T00:00:00Z","timestamp":1767484800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2024M763656"],"award-info":[{"award-number":["2024M763656"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["52503207"],"award-info":[{"award-number":["52503207"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Materials Today Bio"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.mtbio.2026.102764","type":"journal-article","created":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T16:55:01Z","timestamp":1767632101000},"page":"102764","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Intranasal delivery of Odorranalectin-modified lipid nanoparticles for multi-targeted therapy of Alzheimer's disease"],"prefix":"10.1016","volume":"36","author":[{"given":"Yumeng","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changfeng","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yushan","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongjuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shulei","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9389-4928","authenticated-orcid":false,"given":"Hongwei","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mtbio.2026.102764_bib1","doi-asserted-by":"crossref","first-page":"92","DOI":"10.3390\/neurolint17060092","article-title":"Global diseases deserve global solutions: Alzheimer's disease","volume":"17","author":"Twiss","year":"2025","journal-title":"Neurol. Int."},{"key":"10.1016\/j.mtbio.2026.102764_bib2","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1007\/s40265-024-02087-4","article-title":"Donanemab: first approval","volume":"84","author":"Kang","year":"2024","journal-title":"Drugs"},{"key":"10.1016\/j.mtbio.2026.102764_bib3","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/s41392-023-01484-7","article-title":"Amyloid \u03b2-based therapy for Alzheimer's disease: challenges, successes and future","volume":"8","author":"Zhang","year":"2023","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.mtbio.2026.102764_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2022.120861","article-title":"Alzheimer's disease failed clinical trials","volume":"306","author":"Asher","year":"2022","journal-title":"Life Sci."},{"key":"10.1016\/j.mtbio.2026.102764_bib5","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1007\/s40265-023-01938-w","article-title":"Alzheimer's disease: novel targets and investigational drugs for disease modification","volume":"83","author":"Cummings","year":"2023","journal-title":"Drugs"},{"key":"10.1016\/j.mtbio.2026.102764_bib6","first-page":"43","article-title":"Alzheimer's disease puzzle: delving into pathogenesis hypotheses","volume":"15","author":"Nasb","year":"2024","journal-title":"Aging Dis"},{"key":"10.1016\/j.mtbio.2026.102764_bib7","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.3390\/antiox13101208","article-title":"The dual role of amyloid beta-peptide in oxidative stress and inflammation: unveiling their connections in Alzheimer's disease etiopathology","volume":"13","author":"Fanlo-Ucar","year":"2024","journal-title":"Antioxidants"},{"key":"10.1016\/j.mtbio.2026.102764_bib8","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/s41392-020-0207-x","article-title":"Therapeutic siRNA: state of the art","volume":"5","author":"Hu","year":"2020","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.mtbio.2026.102764_bib9","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2024.1393646","article-title":"Principle, application and challenges of development siRNA-based therapeutics against bacterial and viral infections: a comprehensive review","volume":"15","author":"Motamedi","year":"2024","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.mtbio.2026.102764_bib10","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abc7031","article-title":"Blood-brain barrier\u2013penetrating siRNA nanomedicine for Alzheimer's disease therapy","volume":"6","author":"Zhou","year":"2020","journal-title":"Sci. Adv."},{"key":"10.1016\/j.mtbio.2026.102764_bib11","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.jconrel.2018.04.034","article-title":"Systemic delivery of BACE1 siRNA through neuron-targeted nanocomplexes for treatment of Alzheimer's disease","volume":"279","author":"Wang","year":"2018","journal-title":"J. Control. Release Off. J. Control. Release Soc."},{"key":"10.1016\/j.mtbio.2026.102764_bib12","doi-asserted-by":"crossref","first-page":"11753","DOI":"10.1021\/acsnano.3c13150","article-title":"Biomimetic nanovesicles as a dual gene delivery system for the synergistic gene therapy of Alzheimer's disease","volume":"18","author":"Jiang","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.mtbio.2026.102764_bib13","doi-asserted-by":"crossref","first-page":"2884","DOI":"10.1016\/j.apsb.2025.02.035","article-title":"Nose-to-brain delivery of targeted lipid nanoparticles as two-pronged \u03b2-amyloid nanoscavenger for Alzheimer's disease therapy","volume":"15","author":"Xu","year":"2025","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.mtbio.2026.102764_bib14","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2022.999752","article-title":"Promising bioactive properties of quercetin for potential food applications and health benefits: a review","volume":"9","author":"Shabir","year":"2022","journal-title":"Front. Nutr."},{"key":"10.1016\/j.mtbio.2026.102764_bib15","doi-asserted-by":"crossref","first-page":"4863","DOI":"10.3390\/ijms24054863","article-title":"A diet containing rutin ameliorates brain intracellular redox homeostasis in a mouse model of Alzheimer's disease","volume":"24","author":"Bermejo-Besc\u00f3s","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.mtbio.2026.102764_bib16","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232314835","article-title":"The neuroprotective potentiality of flavonoids on Alzheimer's disease","volume":"23","author":"Calderaro","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.mtbio.2026.102764_bib17","article-title":"Mechanistic insights and perspectives involved in neuroprotective action of quercetin","volume":"140","author":"Grewal","year":"2021","journal-title":"Biomed. Pharmacother. Biomedecine Pharmacother."},{"key":"10.1016\/j.mtbio.2026.102764_bib18","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1080\/17460441.2023.2241366","article-title":"Drug design strategies that aim to improve the low solubility and poor bioavailability conundrum in quercetin derivatives","volume":"18","author":"Alizadeh","year":"2023","journal-title":"Expet Opin. Drug Discov."},{"key":"10.1016\/j.mtbio.2026.102764_bib19","doi-asserted-by":"crossref","first-page":"4283","DOI":"10.1021\/acs.accounts.1c00550","article-title":"Lipid nanoparticle-mRNA formulations for therapeutic applications","volume":"54","author":"Wang","year":"2021","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.mtbio.2026.102764_bib20","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1038\/s41578-021-00358-0","article-title":"Lipid nanoparticles for mRNA delivery","volume":"6","author":"Hou","year":"2021","journal-title":"Nat. Rev. Mater."},{"key":"10.1016\/j.mtbio.2026.102764_bib21","doi-asserted-by":"crossref","first-page":"2682","DOI":"10.3390\/pharmaceutics14122682","article-title":"Recent advances in lipid nanoparticles for delivery of mRNA","volume":"14","author":"Yang","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.mtbio.2026.102764_bib22","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1021\/acs.nanolett.4c05186","article-title":"Peptide-functionalized lipid nanoparticles for targeted systemic mRNA delivery to the brain","volume":"25","author":"Han","year":"2025","journal-title":"Nano Lett."},{"key":"10.1016\/j.mtbio.2026.102764_bib23","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/s41392-023-01481-w","article-title":"The blood\u2013brain barrier: structure, regulation and drug delivery","volume":"8","author":"Wu","year":"2023","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.mtbio.2026.102764_bib24","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.70213","article-title":"The nasal\u2013brain drug delivery route: mechanisms and applications to central nervous system diseases","volume":"6","author":"Qiu","year":"2025","journal-title":"MedComm"},{"key":"10.1016\/j.mtbio.2026.102764_bib25","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2024.1463976","article-title":"Recent developments in intranasal drug delivery of nanomedicines for the treatment of neuropsychiatric disorders","volume":"11","author":"Kisku","year":"2024","journal-title":"Front. Med."},{"key":"10.1016\/j.mtbio.2026.102764_bib26","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1046\/j.1365-2567.2000.00932.x","article-title":"Mucosal immunogenicity of plant lectins in mice","volume":"99","author":"Lavelle","year":"2000","journal-title":"Immunology"},{"key":"10.1016\/j.mtbio.2026.102764_bib27","doi-asserted-by":"crossref","DOI":"10.1002\/adfm.202402129","article-title":"A triple\u2010role nano\u2010therapy by NADH@HMONs\u2010AAL for precision treatment of cognitive dysfunction induced by neuroinflammation through the nose\u2010brain pathway","volume":"34","author":"Du","year":"2024","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.mtbio.2026.102764_bib28","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0002381","article-title":"Odorranalectin is a small peptide lectin with potential for drug delivery and targeting","volume":"3","author":"Li","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.mtbio.2026.102764_bib29","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jconrel.2011.02.022","article-title":"Odorranalectin-conjugated nanoparticles: preparation, brain delivery and pharmacodynamic study on Parkinson's disease following intranasal administration","volume":"151","author":"Wen","year":"2011","journal-title":"J. Control. Release Off. J. Control. Release Soc."},{"key":"10.1016\/j.mtbio.2026.102764_bib30","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1089\/hum.2010.083","article-title":"High-density lipoprotein facilitates in vivo delivery of \u03b1-tocopherol\u2013conjugated short-interfering RNA to the brain","volume":"22","author":"Uno","year":"2011","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.mtbio.2026.102764_bib31","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.jconrel.2022.02.017","article-title":"Microfluidic technologies and devices for lipid nanoparticle-based RNA delivery","volume":"344","author":"Maeki","year":"2022","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.mtbio.2026.102764_bib32","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.tips.2021.03.002","article-title":"The importance of apparent pKa in the development of nanoparticles encapsulating siRNA and mRNA","volume":"42","author":"Patel","year":"2021","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.mtbio.2026.102764_bib33","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1021\/acs.molpharmaceut.4c00426","article-title":"Calculating apparent pKa values of ionizable lipids in lipid nanoparticles","volume":"22","author":"Hamilton","year":"2025","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.mtbio.2026.102764_bib34","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.neurobiolaging.2020.12.007","article-title":"Decreased pH in the aging brain and Alzheimer's disease","volume":"101","author":"Decker","year":"2021","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.mtbio.2026.102764_bib35","first-page":"17","article-title":"Oxidative stress and mitochondrial dysfunction in Alzheimer's disease: insights into pathophysiology and treatment, J. Dement","volume":"2","author":"Alkhalifa","year":"2025","journal-title":"Alzheimers Dis."},{"key":"10.1016\/j.mtbio.2026.102764_bib36","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.3390\/antiox11122377","article-title":"Nrf2 regulates oxidative stress and its role in cerebral ischemic stroke","volume":"11","author":"Wang","year":"2022","journal-title":"Antioxidants"},{"key":"10.1016\/j.mtbio.2026.102764_bib37","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/6635460","article-title":"The Keap1\u2010Nrf2 system: a mediator between oxidative stress and aging","volume":"2021","author":"Yu","year":"2021","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.mtbio.2026.102764_bib38","doi-asserted-by":"crossref","first-page":"549","DOI":"10.3390\/biom13030549","article-title":"The role of the transcription factor Nrf2 in Alzheimer's disease: therapeutic opportunities","volume":"13","author":"De Plano","year":"2023","journal-title":"Biomolecules"},{"key":"10.1016\/j.mtbio.2026.102764_bib39","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1217730","article-title":"Natural antioxidants that act against Alzheimer's disease through modulation of the NRF2 pathway: a focus on their molecular mechanisms of action","volume":"14","author":"Sidiropoulou","year":"2023","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.mtbio.2026.102764_bib40","doi-asserted-by":"crossref","first-page":"5474","DOI":"10.3390\/molecules25225474","article-title":"An overview of Nrf2 signaling pathway and its role in inflammation","volume":"25","author":"Saha","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.mtbio.2026.102764_bib41","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1177\/2211068214561025","article-title":"TEER measurement techniques for in vitro barrier model systems","volume":"20","author":"Srinivasan","year":"2015","journal-title":"J. Lab. Autom."},{"key":"10.1016\/j.mtbio.2026.102764_bib42","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1017\/S0007114507812062","article-title":"Free fucose is a danger signal to human intestinal epithelial cells","volume":"99","author":"Chow","year":"2008","journal-title":"Br. J. Nutr."},{"key":"10.1016\/j.mtbio.2026.102764_bib43","article-title":"Intranasal delivery of BACE1 siRNA and rapamycin by dual targets modified nanoparticles for Alzheimer's disease therapy","volume":"18","author":"Yang","year":"2022","journal-title":"Small Weinh. Bergstr. Ger."},{"key":"10.1016\/j.mtbio.2026.102764_bib44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbr.2012.07.016","article-title":"Age-related changes in brain metabolites and cognitive function in APP\/PS1 transgenic mice","volume":"235","author":"Chen","year":"2012","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.mtbio.2026.102764_bib45","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.nbd.2006.08.017","article-title":"Characterization of amyloid deposition in the APPswe\/PS1dE9 mouse model of Alzheimer disease","volume":"24","year":"2006","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.mtbio.2026.102764_bib46","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2024.1459025","article-title":"The role of PI3K signaling pathway in Alzheimer's disease","volume":"16","author":"Pan","year":"2024","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.mtbio.2026.102764_bib47","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1007\/s12192-021-01231-3","article-title":"The PI3K\/akt signaling axis in Alzheimer's disease: a valuable target to stimulate or suppress?","volume":"26","author":"Razani","year":"2021","journal-title":"Cell Stress Chaperones"},{"key":"10.1016\/j.mtbio.2026.102764_bib48","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.9308","article-title":"Lycopene alleviates oxidative stress via the PI3K\/akt\/Nrf2pathway in a cell model of Alzheimer's disease","volume":"8","author":"Fang","year":"2020","journal-title":"PeerJ"},{"key":"10.1016\/j.mtbio.2026.102764_bib49","article-title":"Puerarin inhibited oxidative stress and alleviated cerebral ischemia-reperfusion injury through PI3K\/akt\/Nrf2 signaling pathway","volume":"14","author":"Zhang","year":"2023","journal-title":"Front. Pharmacol."}],"container-title":["Materials Today Bio"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590006426000062?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590006426000062?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T04:32:07Z","timestamp":1778905927000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2590006426000062"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":49,"alternative-id":["S2590006426000062"],"URL":"https:\/\/doi.org\/10.1016\/j.mtbio.2026.102764","relation":{},"ISSN":["2590-0064"],"issn-type":[{"value":"2590-0064","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intranasal delivery of Odorranalectin-modified lipid nanoparticles for multi-targeted therapy of Alzheimer's disease","name":"articletitle","label":"Article Title"},{"value":"Materials Today Bio","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mtbio.2026.102764","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102764"}}